2009 Molecular Biology of Hepatitis B Viruses Meeting

2009年乙型肝炎病毒分子生物学会议

• 批准号: 7674473
• 负责人: JOHN Marston TAYLOR
• 金额: $ 2.2万
• 依托单位: HEPATITIS B FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-15 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7674473
• 关键词: Address; Antiviral Therapy; Basic Science; Cessation of life; Cirrhosis; Educational workshop; Foundations; France; Funding; Hepatitis B; Hepatitis B Virus; Hepatitis D; Hepatitis Delta Virus; Home environment; Immune response; Immunity; Individual; Infection; International; Liver Failure; Minority; Molecular Biology; Morphogenesis; Natural Immunity; Oral; Primary carcinoma of the liver cells; Public Health; Research Personnel; Schedule; Scientist; Series; Structure; Therapeutic; Time; Underrepresented Minority; United States National Institutes of Health; Universities; Vaccinated; Vaccines; Viral; Virus; Virus Diseases; cost; meetings; posters; prophylactic; virus host interaction

DESCRIPTION (provided by applicant): This proposal is intended to apply for funding support for the expenses necessary to host the 2009 Molecular Biology of Hepatitis B Viruses Meeting, scheduled August 30 through September 2, 2009 at the Vinci International Convention Center, Loire Valley, Tours, France. This is the next scheduled meeting in an annual series that has been held continuously since 1985. This meeting represents the only meeting that brings together basic scientists in the field of hepatitis B virus (HBV) and hepatitis D (delta) virus (HDV) from around the world. HBV continues to be a major global and US public health problem. Despite the availability of prophylactic vaccines, many new infections occur worldwide, partly because of the lack of an immune response in some (d10%) of the vaccinated people, but mostly because of underutilization of the vaccine, due to cost and other issues. Moreover, for the more than 350 million people already chronically infected with HBV (approximately 15 million of whom are co- infected with HDV), the vaccine is of no therapeutic value. As a result, between 0.5 and 1 million people die of HBV/HDV every year worldwide. It is, therefore, imperative that basic research and the scientific exchange among those studying HBV/HDV continue and the annual HBV meeting represents the venue at which this can occur. The 2009 meeting will continue in this tradition by enhancing the interaction and dialogue with 10 oral scientific sessions, 2 poster sessions as well as less structured "networking" time. A special focus of this meeting will be on viral morphogenesis, viral entry, host-virus interactions, with a special emphasis on antiviral therapy and innate immunity. This will be facilitated by one immunity-related keynote address accompanying a special workshop focused on innate immunity. As always, great effort has been made to minimize the cost of the meeting. Furthermore, the Hepatitis B Foundation has made a strong commitment to support this meeting since 2005, in terms of providing a permanent home for organizing the meeting and making its staff available for organizing the meeting and publicizing it, especially to universities with large numbers of underrepresented minorities. In order to allow the participation of junior and minority investigators, support from the NIH to help defray the meeting costs of junior scientists is requested. Limited support for meeting materials and organizational functions is also needed.

描述(由申请者提供)：本提案旨在申请资金支持，用于主办2009年8月30日至9月2日在法国卢瓦尔河谷芬奇国际会议中心举行的2009年乙肝病毒分子生物学会议。这是自1985年以来连续举行的年度系列会议中的下一次预定会议。这次会议是唯一一次汇聚了来自世界各地的乙肝病毒(乙肝)和丁型肝炎(德尔塔)病毒(HDV)领域基础科学家的会议。乙肝病毒仍然是全球和美国的主要公共卫生问题。尽管有预防性疫苗可用，但世界各地仍发生许多新感染病例，部分原因是部分(D10%)接种疫苗的人缺乏免疫反应，但主要是由于成本和其他问题导致疫苗未得到充分利用。此外，对于3.5亿多已经慢性感染乙肝病毒的人(其中约1500万人同时感染HDV)来说，疫苗没有治疗价值。因此，全世界每年有50万至100万人死于乙肝病毒/HDV。因此，当务之急是继续基础研究和研究乙肝病毒/丁型肝炎病毒的人之间的科学交流，而一年一度的乙肝病毒会议是进行这一交流的场所。2009年会议将延续这一传统，通过10次口头科学会议、2次海报会议以及较少安排的“联网”时间来加强互动和对话。这次会议的一个特别焦点将是病毒的形态发生、病毒进入、宿主与病毒的相互作用，特别强调抗病毒治疗和先天免疫。这将由一次与免疫有关的主旨发言推动，同时还将举行一次以先天免疫为重点的特别讲习班。一如既往，我们作出了巨大努力，将会议费用降至最低。此外，自2005年以来，乙肝基金会一直坚定地致力于支持这次会议，为会议的组织提供一个永久的住所，并为会议的组织和宣传提供工作人员，特别是在少数族裔人数较少的大学。为了允许初级和少数族裔调查人员参与，要求美国国立卫生研究院提供支持，以帮助支付初级科学家的会议费用。对会议材料和组织职能的支持也是有限的。